Track 1. Stem Cell:

Stem cells are the body's raw materials cells from which all other cells with specialized functions are generated. Stem cells originate from two main sources: adult body tissues and embryos. Stem cells are unspecialized cells of the human body. Stem cells are special human cells that have the ability to develop into many different cell types, from muscle cells to brain cells.

Track 2. Gene Therapy:

Gene therapy is an experimental technique that uses genes to treat or prevent disease. Gene therapy is designed to introduce genetic material into cells to compensate for abnormal genes or to make a beneficial protein. Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. Human gene therapy seeks to modify or manipulate the expression of a gene or to alter the biological properties of living.

Track 3. Pluripotency:

Pluripotent cells can give rise to all of the cell types that make up the body; embryonic stem cells are considered pluripotent. Pluripotent stem cells have the ability to undergo self-renewal and to give rise to all cells of the tissues of the body. A pluripotent cell is able to develop into several different types of cell: Embryonic stem cells are said to be more pluripotent than adult stem cells.

Track 4. Genome Reprogramming:

Reprogramming is the process of changing one cell fate to another, particularly in the context of converting a mature differentiated cell into a less-committed precursor. Reprogramming of genomes during imprinting in the germline requires a stepwise cycle of erasure and re-initiation of imprints.

Track 5. Molecular Biology:

Molecular biology, the field of science concerned with studying the chemical structures and processes of biological phenomena involving molecules. Molecular biology looks at the molecular mechanisms behind processes such as replication, transcription, translation, and cell function.

Track 6. Cancer Stem Cells:

Cancer stem cells are a small subpopulation of self-renewing malignant and oncogenic cells that drive tumor initiation and progression. Cancer stem cells are rare immortal cells within a tumour that can both self-renew by dividing and give rise to many cell types that constitute the tumour and can therefore form tumours. Cancer stem cells are a class of pluripotent cells that have been observed in most types of solid and hematologic cancers.

Track 7. Multipotent Stem Cells:

Multipotent stem cells have the ability to differentiate into all cell types within one particular lineage. Multipotent stem cells can be harvested from adipose tissues, bone marrow, and other organs.

Track 8. Unipotent Stem Cells:

Unipotent stem cells usually have the ability to differentiate into a single cell type, despite having the property of self-renewal. Unipotent stem cells give rise to cells of their own type along a single lineage. As such, unipotent stem cells have the lowest differentiation potential compared to other types of stem cells.

Track 9. Hematopoietic Stem Cells:

Hematopoietic stem cells are found in the peripheral blood and the bone marrow. Hematopoietic stem cells are defined as cells that are capable of self-renewal and that differentiate into all mature hematopoietic cells in the body.

Track 10. Cell & Organ Regeneration:

Cell & Organ regeneration is a promising therapy that can alleviate humans from diseases that have not been yet cured. Regeneration means the regrowth of a damaged or missing organ part from the remaining tissue. Organ regeneration is a process not fully yet understood. However, when its underlying mechanisms are unraveled, it holds tremendous therapeutic potential for humans.

Track 11. Tissue Engineering:
Tissue engineering can perhaps be best defined as the use of a combination of cells, engineering materials, and suitable biochemical factors to improve or replace biological functions. Tissue engineering, scientific field concerned with the development of biological substitutes capable of replacing diseased or damaged tissue in humans.

Track 12. Stem Cell in Drug Development:
Stem cells for treating disease were largely focused on regeneration and the ability to repair tissues in the body through cell therapies. However, as technologies have advanced, the focus is shifting to using stem cells in drug discovery applications such as compound screening, toxicity testing, target identification, and disease modelling.

Track 13. Stem Cell Technology:

Stem cell technology is a rapidly developing field that combines the efforts of cell biologists, geneticists, and clinicians and offers hope of effective treatment for a variety of malignant and non-malignant diseases. Stem Cell Technologies develops cell culture media, cell separation systems, instruments, and other reagents for use in life sciences research.

Track 14. Stem Cells in Disease Modelling:

Stem cell science is among the fastest-moving fields in biology, with many highly promising directions for translatability. Disease modelling has enabled scientists to study a range of human diseases in the lab, overcoming many of the challenges of obtaining donor tissues from patients. Recent advances in genome editing in stem cells to recapitulate in vitro “disease in dish” promises a better understanding of underlying biological mechanisms of human diseases.

Track 15. Stem Cell Banking:

Stem cell banking is the process of storing precious umbilical cord blood obtained at the time of delivery for potential use in the future. Stem cell banking offers a healthy future for not just your baby but the entire family.

Track 16. Cell and Gene Therapy:

Cell therapy aims to treat diseases by restoring or altering certain sets of cells or by using cells to carry a therapy through the body. With cell therapy, cells are cultivated or modified outside the body before being injected into the patient.

Gene therapy aims to treat diseases by replacing, inactivating, or introducing genes into cells either inside the body (in vivo) or outside of the body (ex vivo).

Track 17. Stem Cell Transplant (SCT):
Stem cell transplantation, sometimes referred to as bone marrow transplant is a procedure in which a patient receives healthy stem cells to replace damaged stem cells. Before Stem cell transplantation, the patient receives high doses of chemotherapy, and sometimes radiation therapy, to prepare the body for transplantation. This is called "conditioning treatment".

The main types of SCT:

1. Autologous Transplantation
2. Allogeneic Transplantation

Track 18. Genome Editing:

Genome editing is a method that lets scientists change the DNA of many organisms, including plants, bacteria, and animals. Editing DNA can lead to changes in physical traits, like eye color, and disease risk. Scientists use different technologies to do this. These technologies act like scissors, cutting the DNA at a specific spot. Then scientists can remove, add, or replace the DNA where it was cut.

Track 19. Stem Cell Pathology:

Stem cell pathology is the study of pursuing and clarifying the etiology of diseases. The Department of Pathology aims at contributing to early diagnosis and early treatment by helping future doctors of clinical pathology to make an accurate judgment of human tissues obtained by biopsy or at the surgery.

Track 20. Apoptosis of Stem Cells:

The apoptosis of stem cells plays an important role in many ways, such as it can keep the balance of the cell number, and it functions in tissue generation.

Track 21. Somatic Stem Cells:

Somatic stem cells are also called adult stem cells. Adult stem cells supply new cells as an organism grows and replace cells that get damaged. Adult stem cells are said to be multipotent, which means they can only change into some cells in the body, not any cell.

Track 22. Computational Stem Cell Biology:

Computational biology is enabling explosive growth in our understanding of stem cells and our ability to use them for disease modelling, regenerative medicine, and drug discovery.

The global stem cells market size generated a revenue of USD 9.38 billion in 2020. It is expected to expand at a compound annual growth rate (CAGR) of 8.8% from 2021 to 2028. The factors contributing to the growth include increasing demand for biologics, technological advancement in stem cell therapeutics, and a growing focus on the development of personalized medicines. The adult stem cells (ASCs) segment dominated the market in 2020, with a share of 85.7%. The primary factors that contributed to the dominance of the segment include the presence of minimal controversial issues concerning ethics, immune-rejection, and tumorigenesis. The application of ASCs in regenerative medicines can be further attributed to the segment growth. The ASCs bioprocessing for regenerative medicine is anticipated to face challenges during process development. The application segment can be further divided into regenerative medicine and drug discovery and development. Regenerative medicine is held the largest market share of 89.1% in 2020 owing to increasing approval for stem cell therapies clinical trials targeting different diseases.